Chronic lymphocytic leukemia in dogs and cats: The veterinary perspective

Veterinary Clinics of North America - Small Animal Practice

Volumn 33, Issue 6, 2003, Pages 1379-1399

  Workman, Heather C ^a   Vernau, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD1 ANTIGEN; CD11 ANTIGEN; CD18 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD79A ANTIGEN; CD8 ANTIGEN; CHLORAMBUCIL; CLADRIBINE; COMPLEMENT COMPONENT C3D RECEPTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUDARABINE; MONOCLONAL ANTIBODY; PENTOSTATIN; PREDNISONE; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CANCER INCIDENCE; CAT DISEASE; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CLONAL VARIATION; CYTOCHEMISTRY; CYTOGENETICS; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOG DISEASE; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOSIS; MEDICAL ASSESSMENT; MOLECULAR GENETICS; NATURAL KILLER CELL; NONHUMAN; PROGNOSIS; SEX DIFFERENCE; T LYMPHOCYTE; VETERINARY MEDICINE;

CANIS FAMILIARIS; FELIS CATUS;

EID: 0348134481     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00120-7     Document Type: Review

References (59)

1. Foon KA. Chronic lymphoid leukemias: recent advances in biology and therapy. Stem Cells 1995;13(1):1-21.
2. Jandl JH. Blood: textbook of haematology. 2nd edition. Boston: Little Brown; 1996.
3. Foucar K. B cell chronic lymphocytic and prolymphocytic leukemia. In: Knowles DM, editor. Neoplastic hematopathology. 1st edition. Baltimore: Williams & Wilkins; 1992. p. 1181-208.
4. Hoyer JD, Ross CW, Li CY, et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood 1995;86(3):1163-9.
5. Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997;90(8):2863-92.
6. Wong KF, Chan JK, Sin VC. T-cell form of chronic lymphocytic leukaemia: a reaffirmation of its existence. Br J Haematol 1996;93(1):157-9.
7. Hodgkins EM, Zinkl JG, Madewell BR. Chronic lymphocytic leukemia in the dog. J Am Vet Med Assoc 1980;177(8):704-7.
8. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American- British (FAB) Cooperative Group. J Clin Pathol 1989;42(6):567-84.
9. Davis BH, Foucar K, Szczarkowski W, et al. US-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry 1997;30(5):249-63.
10. Withrow SJ, MacEwan EG. Small animal clinical oncology. 3rd edition. Philadelphia: WB Saunders; 2001.
11. Vernau W, Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 1999;69(2-4):145-64.
12. Harvey JW, Terrell TG, Hyde DM, Jackson RI. Well-differentiated lymphocytic leukemia in a dog: long-term survival without therapy. Vet Pathol 1981;18(1):37-47.
13. Giraudel JM, Pages JP, Guelfi JF. Monoclonal gammopathies in the dog: a retrospective study of 18 cases (1986-1999) and literature review. J Am Anim Hosp Assoc 2002; 38(2):135-47.
14. McDonough SP, Moore PF. Clinical, hematologic, and immunophenotypic characterization of canine large granular lymphocytosis. Vet Pathol 2000;37(6):637-46.
15. Leifer CE, Matus RE. Chronic lymphocytic leukemia in the dog: 22 cases (1974-1984). J Am Vet Med Assoc 1986;89(2):214-7.
16. Couto CG, Hammer AS. The cat: diseases and clinical management. 2nd edition. New York: Churchill Livingstone; 1994.
17. Holzworth J. Leukemia and related neoplasms in the cat. I. Lymphoid malignancies. J Am Vet Med Assoc 1960;136(2):47-69.
18. Thrall MA. Lymphoproliferative disorders. Vet Clin North Am Small Anim Pract 1981; 11:321-47.
19. Kipps TJ. Chronic lymphocytic leukemia and related diseases. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams' hematology. New York: McGraw-Hill; 1995. p. 1017-39.
20. Schriever F, Huhn D. New directions in the diagnosis and treatment of chronic lymphocytic leukaemia. Drugs 2003;63(10):953-69.
21. Brown TTJ, Suter MM, Slauson DO. Immunopathology. In: Slauson DO, Cooper BJ, editors. Mechanisms of disease: a textbook of comparative general pathology. 3rd edition. St. Louis: Mosby; 2002. p. xiii, 445.
22. Byrne KM, Kim HW, Chew BP, Reinhart GA, Hayek MG. A standardized gating technique for the generation of flow cytometry data for normal canine and normal feline blood lymphocytes. Vet Immunol Immunopathol 2000;73(2):167-82.
23. Faldyna M, Leva L, Knotigova P, Toman M. Lymphocyte subsets in peripheral blood of dogs a flow cytometric study. Vet Immunol Immunopathol 2001;82(1-2):23-37.
24. Ghernati I, Corbin A, Chabanne L, et al. Canine large granular lymphocyte leukemia and its derived cell line produce infectious retroviral particles. Vet Pathol 2000; 37(4):310-7.
25. Helfand SC, Modiano JF. Chronic lymphocytic leukemia. In: Feldman BF, Zinkl JG, Jain NC, editors. Schalm's veterinary hematology. 5th edition. Baltimore: Lippincott Williams & Wilkins; 2000. p. 638-41.
26. Danilenko DM, Moore PF, Rossitto PV. Canine leukocyte cell adhesion molecules (LeuCAMs): characterization of the CD11/CD18 family. Tissue Antigens 1992;40(1):13-21.
27. Danilenko DM, Rossitto PV, Van der Vieren M, et al. A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8 + lymphocyte subpopulation in peripheral blood. J Immunol 1995;155(1):35-44.
28. Moore PF, Rossitto PV, Danilenko DM. Canine leukocyte integrins: characterization of a CD18 homologue. Tissue Antigens 1990;36(5):211-20.
29. Stromberg PC, Vogtsberger LM. Pathology of the mononuclear cell leukemia of Fischer rats. I. Morphologic studies. Vet Pathol 1983;20(6):698-708.
30. Stromberg PC, Vogtsberger LM, Marsh LR, Wilson FD. Pathology of the mononuclear cell leukemia of Fischer rats. II. Hematology. Vet Pathol 1983;20(6):709-17.
31. Codner EC, Farris-Smith LL. Characterization of the subclinical phase of ehrlichiosis in dogs. J Am Vet Med Assoc 1986;189(1):47-50.
32. Reyers F, Leisewitz AL, Lobetti RG, Milner RJ, Jacobson LS, van Zyl M. Canine babesiosis in South Africa: more than one disease. Does this serve as a model for falciparum malaria? Ann Trop Med Parasitol 1998;92(4):503-11.
33. Helfand SC, Soergel SA, MacWilliams PS, Hank JA, Sondel PM. Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs. Cancer Immunol Immunother 1994;39(2):84-92.
34. Shelton GH, Linenberger ML, Persik MT, Abkowitz JL. Prospective hematologic and clinicopathologic study of asymptomatic cats with naturally acquired feline immunodeficiency virus infection. J Vet Intern Med 1995;9(3):133-40.
35. Lappin MR, George JW, Pedersen NC, Barlough JE, Murphy CJ, Morse LS. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats. J Parasitol 1996;82(5):733-42.
36. Jergens AE. Inflammatory bowel disease: current perspectives. Vet Clin North Am Small Anim Pract 1999;29:501-21.
37. Richter KP. Lymphocytic-plasmacytic enterocolitis in dogs. Semin Vet Med Surg (Small Anim) 1992;7(2):134-44.
38. Dennis JS, Kruger JM, Mullaney TP. Lymphocytic/plasmacytic colitis in cats: 14 cases (1985-1990). J Am Vet Med Assoc 1993;202(2):313-8.
39. Moore PF, Affolter VK, Olivry T, Schrenzel MD. The use of immunological reagents in defining the pathogenesis of canine skin diseases involving proliferation in leukocytes. In: Kwochka K, Willemse T, von Tscharner C, editors. Advances in veterinary dermatology. Oxford: Butterworth Heinemann; 1998. p. 77-94.
40. Freedman AS. Cell surface antigens in leukemias and lymphomas. Cancer Invest 1996;14(3):252-76.
41. Moore PF, Rossitto PV. Development of monoclonal antibodies to canine T cell receptor complex (TCR/CD3) and their utilization in the diagnosis of T cell neoplasia [abstract]. Vet Pathol 1993;30:457.
42. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, Severns E. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 1992;40(2): 75-85.
43. Woo JC, Moore PF. A feline homologue of CD1 is defined using a feline-specific monoclonal antibody. Tissue Antigens 1997;49(3 Part 1):244-51.
44. Roccabianca P, Woo JC, Moore PF. Characterization of the diffuse mucosal associated lymphoid tissue of feline small intestine. Vet Immunol Immunopathol 2000;75(1-2): 27-42.
45. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996;87(1):1-13.
46. McSweeney PA, Rouleau KA, Wallace PM, et al. Characterization of monoclonal antibodies that recognize canine CD34. Blood 1998;91(6):1977-86.
47. Berliner N. T gamma lymphocytosis and T cell chronic leukemias. Hematol Oncol Clin North Am 1990;4(2):473-87.
48. Novotney CA, Gebhard DH, Page RL, McEntee MC, Grindem CB. Immunophenotypic characterization of canine CLL. Presented at the Veterinary Cancer Society, Auburn, AL, November 4-6, 1990. p. 22-3.
49. Ruslander DA, Gebhard DH, Tompkins MB, Grindem CB, Page RL. Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo 1997;11(2):169-72.
50. Butler JE. Immunoglobulin diversity, B-cell and antibody repertoire development in large farm animals. Rev Sci Tech 1998;17(1):43-70.
51. Janeway C, Travers P. Immunobiology: the immune system in health and disease. 3rd edition. London: Garland Publishing; 1997.
52. McCarthy KP. Molecular diagnosis of lymphomas and associated diseases. Cancer Metastasis Rev 1997;16(1-2):109-25.
53. Dreitz MJ, Ogilvie G, Sim GK. Rearranged T lymphocyte antigen receptor genes as markers of malignant T cells. Vet Immunol Immunopathol 1999;69(2-4):113-9.
54. Burnett RC, Vernau W, Modiano JF, Olver CS, Moore PF, Avery AC. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 2003;40(1):32-41.
55. O'Brien S, del Giglio A, Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 1995;85(2):307-18.
56. Theilen GH, Madewell BR. Veterinary cancer medicine. 2nd edition. Philadelphia: Lea & Febiger; 1987.
57. Montserrat E, Bosch F, Rozman C. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives. J Intern Med Suppl 1997;740:63-7.
58. DeVita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2001.
59. Mavromatis B, Cheson BD. Monoclonal antibody therapy of chronic lymphocytic leukemia. J Clin Oncol 2003;21(9):1874-81.